Back to StakeholdersPrimary Platform Link
Categories
1 domain / 2 areas / 1 specialization
Wake Network, Inc.
1 Trial
Psilocybin-focused organization with integration and program infrastructure, including digital and genomics-oriented support claims around therapeutic deployment.
Technology, Data, & Software Snapshot
Digital TherapeuticsPlatform Model
Digital Therapeutics Product
Deployment
Research / Managed Service
Geography
Regional
Coverage
Coverage not set
Customer Types
Clinical Providers / NetworksPatient / Consumer Populations
Capability Focus Areas
Digital Care PathwaysProtocol / Decision Support
Data Modalities
Behavioral / Survey Data
Technology Notes
Wake materials describe psilocybin microdose program infrastructure and integration-therapy development claims relevant to digital therapeutic support workflows.
Verification
Verified
Psychedelic Focus
Explicit Psychedelic Focus
Engagement Status
Active
Last Verified
Apr 9, 2026
Quick Facts
- Type
- biotech
- Website
- Visit